Enkephalin systems in diencephalon and brainstem of the rat by Khachaturian, Henry et al.
THE JOURNAL OF COMPARI1TIVE NEUROLOGY 220:310-320 (19113) 
Enkephalin Systems in Diencephalon and 
Brainstem of the Rat 
HENRY KHACHATURIAN, MICHAEL E. LEWIS, AND STANLEY J. WATSON 
Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan 48105 
ABSTRACT 
The immunocytochemical distribution of [Leulenkephalin and an adre- 
nal enkephalin precursor fragment (BAM-22P) immunoreactivity was inves- 
tigated in the diencephalon and brainstem of rats pretreated with relatively 
high doses of colchicine (300-400 pgil0 pl intracerebroventricularly). The 
higher ranges of colchicine pretreatment allowed the visualization of exten- 
sive enkephalincontaining systems in these brain regions, some of which 
are reported for the first time. Immunoreactive perikarya were found in 
many hypothalamic and thalamic nuclei, interpeduncular nucleus, substan- 
tia nigra, the colliculi, periaqueductal gray, parabrachial nuclei, trigeminal 
motor and spinal nuclei, nucleus raphe magnus and other raphe nuclei, nu- 
cleus reticularis paragigantocellularis, vestibular nuclei, several nor- 
adrenergic cell groups, nucleus tractus solitarius, as well as in the spinal 
cord dorsal horn. In addition to the above regions, immunoreactive fibers 
were also noted in the habenular nuclei, trigeminal sensory nuclei, locus 
coeruleus, motor facial nucleus, cochlear nuclei, dorsal motor nucleus of the 
vagus, and hypoglossal nucleus. When adjacent sections to those stained for 
Peulenkephalin were processed for BAM-22P immunoreactivity, it was 
found that these two immunoreactivities were distributed identically at  
almost all anatomical locations. BAM-22P immunoreactivity was generally 
less pronounced and was preferentially localized to neuronal perikarya. The 
results of the present as well as the preceding studies (Khachaturian et al., 
'83) strongly suggest substantial structural similarity between the adrenal 
proenkephalin precursor and that which occurs in the brain. Also discussed 
are some differences and parallels between the distribution of [Leulenkeph- 
alin and dynorphin immunoreactivities. 
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Methionine [Met]- and leucine [Leulenkephalin are opioid 
pentapeptides that occur in both the brain (Hughes et al., 
'75) and adrenal gland (cf. Kimura et  al., '80). In the adrenal 
medulla, molecular cloning of cDNA from proenkephalin 
mRNA has revealed the structure of the enkephalin pre- 
cursor (Comb et al., '82; Gubler et al., '82; Noda et al., '82). 
The precursor contains fours copies of [Metlenkephalin, 
and single copies of [Leulenkephalin, [Metlenkephalin- 
Arg"-Phe', and [Met]enkephalin-Arg6-Gly'-LeuB, which are 
contained within longer peptide sequences, such as BAM- 
22P and peptides I, F, E, and B. The biosynthesis of the 
enkephalins is distinct from that of either Pendorphin 
(Mains et  al., '77; Roberts and Herbert, '77; Nakanishi et 
al., '79) or dynorphin (Kakidani et al., '82). 
The enkephalins have a wide distribution within the cen- 
tral nervous system, with highest radioimmunoassayable 
levels occurring in the striatum, and next the diencepha- 
lon, brainstem, and cortical-limbic areas (Rossier et al., 
'77; Yang et al., '77; Kobayashi et al., '78; Miller et al., '78). 
[Met]- and [Leulenkephalin have also been immunocyto- 
chemically localized in many brain sites (Elde et al., '78; 
Watson et al., '77a, '78; Hokfelt et al., '77a,b, '79; Simantov 
et al., '77; Bloom et al., '78; Sar et al., '78; Uhl et al., '78, '79; 
Rossier et al., '79; Jacobowitz et  al., '79; Wamsley et al., '80; 
Micevych and Elde, '80; Pickel et al., '80; Finley et al., '81.; 
Gall et al., '81; Khachaturian et  al., '83). The concentrations 
of the enkephalins in some brain sites, such as the cerebral 
cortex and some limbic regions, are apparently too low t o  
be detected immunocytochemically without colchicine pre- 
treatment. Studies using varying doses of colchicine have 
shown enkephalin-positive fibers (Sar et al., '78; Wamsley 
et al., '80) as well as perikarya (Gall et al., '81; Finley et al., 
'81) in the cerebral cortex and certain limbic structures. 
More recently, using relatively high doses of colchicinle 
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mount. Observations and photographs were made with a 
Leitz Orthoplan microscope. 
[Leulenkephalin antiserum was purified by affinity chro- 
matography (March et al., '74). The amino terminus of the 
peptide was covalently linked to a cyanogen bromide-acti- 
vated Sepharose-4B column and the crude anti[Leu]en- 
kephalin serum was passed through the column in order to 
absorb and concentrate specific IgG molecules with affin- 
ity toward [Leulenkephalin. The resultant purified, car- 
boxyl terminus-directed antiserum yields a much im- 
proved immunocytochemical signal with greatly reduced 
background (Watson and Akil, '81). Also, for comparative 
purposes, we have employed antisera generated against 
BAM-22P (antiserum 'Tristan,' Hollt et al., '81), serotonin 
(our own), and tyrosine hydroxylase (supplied by Dr. T. 
Joh, Cornell University). 
RESULTS 
[Leulenkephalin immunoreactivity is localized to peri- 
karya and processes of neurons in many diencephalic, 
brainstem, and spinal cord structures (see Fig. 1). [LeuJen- 
kephalin-positive perikarya are found in many hypotha- 
lamic and thalamic nuclei, interpeduncular nucleus, sub- 
stantia nigra and other dopaminergic cell group areas, the 
colliculi, periaqueductal gray, nucleus raphe dorsalis 
(mostly lateral to), raphe magnus and other serotonergic 
raphe nuclei, parabrachial nuclei, motor trigeminal nu- 
cleus, spinal trigeminal nucleus, nucleus reticularis gigan- 
tocellularis and paragigantocellularis, several vestibular 
nuclei, several noradrenergic cell group areas, nucleus trac- 
tus solitarius, and spinal cord dorsal horn. Additionally 
[Leulenkephalin-positive fibers or terminals are seen in all 
of the above regions, and further in habenular nuclei, locus 
coeruleus, main sensory trigeminal nucleus, motor facial 
nucleus, cochlear nuclei, dorsal motor nucleus of vagus, 
and hypoglossal nucleus. When sections adjacent to those 
processed for Feulenkephalin immunoreactivity were 
analyzed for BAM-22P immunoreactivity, a very similar 
anatomical patterning was noted between the distribution 
of [Leulenkephalin and the precursor fragment immuno- 
reactivities (see Fig. 6A,B). However, BAM-22P immuno- 
reactivity was generally less pronounced than [Leulen- 
kephalin immunoreactivity and tended to be localized 
preferentially to neuronal perikarya. Thus, although most 
regions which showed [Leuknkephalin-positive perikarya 
and fibers also contained BAM-22P immunoreactivity, 
certain areas did not demonstrate BAM-22P-positive fi- 
bers or terminals. These regions include the supraoptic 
and anterior hypothalamic nuclei, periventricular and lat- 
eral geniculate nuclei of thalamus, inferior colliculus, 
motor trigeminal nucleus, nucleus reticularis gigantocellu- 
laris, lateral, superior, and spinal vestibular nuclei, and the 
cochlear nuclei. 
The immunoreactive signal obtained by using either 
[Leulenkephalin or BAM-22P was much enhanced in col- 
chicine-pretreated animals compared to untreated rats. 
Perikaryal staining, especially of smaller classes of neu- 
rons, was best demonstrated after relatively high doses of 
colchicine (300-400 pg). These doses of colchicine also en- 
hanced the visualization of dendritic and axonal processes. 
The immunoreactive signal obtained by using Leulen- 
kephalin or BAM-22P antisera was completely abolished 
by the addition of 1 pM [Leulenkephalin or BAM-22P, re- 
spectively, to the primary rabbit antiserum prior to incu- 
bation. Cross-blocking paradigms further demonstrated 
(300-400 pg, intracerebroventricularly), we have been able 
to visualize extensive cortical-limbic and other telence- 
phalic enkephalinergic systems (Khachaturian et al., '83). 
Furthermore, in that study, we also used antisera against 
BAM-22P, a bovine adrenal medullary enkephalin precur- 
sor fragment (Mizuno et  al., '80), to demonstrate an ana- 
tomical similarity between the distributions of [Leu]- 
enkephalin and BAM-22P in the rat telencephalon, thus 
providing evidence for the existence in rat brain of an 
enkephalin biosynthetic mechanism similar to that found 
in the adrenal gland. We now report on the codistribution 
of [Leulenkephalin and BAM-22P immunoreactivities in 
diencephalic and other brainstem sites as well as in the 
spinal cord. 
MATERIALS AND METHODS 
Adult male Sprague-Dawley rats were anesthetized with 
sodium pentobarbital and given colchicine (300-400 pgil0 
p l  normal saline) intracerebroventricularly, approximately 
48 hours prior to perfusion. The rats were reanesthetized 
with sodium pentobarbital (50 mgiml injected intraperi- 
toneally), and the cardiovascular system was flushed with 
50 ml of ice-cold 0.9% saline through the left ventricle, 
with the right atrium cut open. The ventricles were excised 
immediately and a cannula was inserted into the aorta, 
through which the animal was perfusion-fixed with ice- 
cold 0.1 M phosphate-buffered 4% formaldehyde (pH 7.4) 
at 140 mm Hg for 30 minutes. The brains from these rats 
were blocked and refrigerated overnight in phosphate- 
buffered 15% sucrose, and then frozen by immersion in 
-40°C isopentane for 30-40 seconds, and stored at 
-70°C. Sections were cut at 2O-pr1-1 thickness in a cryostat 
(-20°C) and mounted onto subbed slides. 
For peroxidase-antiperoxidase immunocytochemistry 
(Watson et al., '77b), frozen tissue sections were allowed to 
air-dry at room temperature and were then incubated 
(37°C) with normal goat serum (NGS, from GIBCO) at  a 
dilution of 1/30 for approximately 5-10 minutes, followed 
by primary rabbit antisera to specific substances diluted 
with 0.02 M phosphate-buffered saline (PBS) and 0.3% Tri- 
ton X-100, for 1 hour, and overnight at 4°C. Control sec- 
tions were incubaled with antiserum preadsorbed with 1- 
20 pM concentrations of peptide against which the antise- 
rum was raised, as well as with other peptides having 
amino acid sequences similar to  the peptide in question. 
For these cross-blocking studies, [Leulenkephalin and 
BAM-22P antisera were preadsorbed with [Leulenkepha- 
lin, [Metlenkephalin, BAM-22P, BAM-12P, peptide E, dy- 
norphin A, or 0-endorphin. The following day, the tissues 
were washed in PBS and incubated with NGS for 5-10 
minutes at 37"C, and then goat-antirabbit serum (Stern- 
berger-Meyer) at l i l00 dilution for 30 minutes, and over- 
night at 4°C. The next day, the tissues were washed in 
PBS, incubated at  37°C with NGS for 5-10 minutes, fol- 
lowed by antihorseradish peroxidase (HRP) serum at U200 
dilution for 40 minutes, Again, the tissues were washed in 
PBS and incubated at 37°C with 4 pglml HRP enzyme 
(Sigma, type VI) for another 40 minutes. The peroxidase 
reaction was initiated by the immersion of the tissues in a 
solution of 0.03% H,O, and 0.125 mgiml diaminobenzidine 
(Sigma) for 15 minutes at room temperature, with constant 
stirring. The tissues were washed in distilled water, osmi- 
cated (2% OsO,) briefly, washed, dehydrated through 
graded ethanols and xylenes, and coverslipped with Per- 
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the specificity of each antiserum: [Leulenkephalin immu- 
noreactivity was not blocked by 20 FM BAM-22P, peptide 
E, dynorphin A, or @-endorphin. Likewise, the BAM-22P 
signal was not blocked by 20 pM [Met]- or [Leulenkephalin, 
BAM-12P, peptide E, dynorphin A, or @-endorphin. 
In the preoptic region, small [Leulenkephalin immunore- 
active perikarya are densely packed in the medial preoptic 
area and scattered in the lateral preoptic area. Within the 
hypothalamus proper, [Leulenkephalin-positive perikarya 
are scattered throughout the anterior hypothalamic area, 
periventricular, dorsomedial, and arcuate nuclei, lateral 
and posterior hypothalamic areas, as well as medial re- 
gions of the medial mammillary (Fig. 2B) and lateral mam- 



























































Dorsal motor nucleus, vagus 
Hypoglossal nucleus 
Area of noradrenergic cell group A5 
Amygdala, anterior area 
Amygdala, basolateral nucleus 
Anterior commissure 
Nucleus accumbens 
Amygdala, central nucleus 
Amygdala, cortical nucleus 
Anterodorsal nucleus, thalamus 
Anterior hypothalamic area 
Anteromedial nucleus, thalamus 
Nucleus ambiguus 
Amygdala, medial nucleus 
Anterior olfactory nucleus 
Arcuate nucleus 
Anteroventral nucleus, thalamus 




Central-medial nucleus, thalamus 
Cochlear nuclear complex 
Caudate-putamen 
Corticospinal tract 
Central tegmental nucleus 
Dorsal funiculus, spinal cord 
Dorsal horn, spinal cord 
Dentate gyrus 
Dorsal nucleus lateral lemniscus 
Dorsomedial nucleus. thalamus 
Dorsomedial nucleus, hypothalamus 
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Entorhinal cortex 
Fastigid nucleus, cerebellum 
Frontal cortex 
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Glomerular layer, olfactory bulb 
Globus pallidus 
Lateral habenular nucleus 
Medial habenular nucleus 
Hippocampus 
Inferior colliculus 
Interpeduncular nuclear complex 
Nucleus locus coeruleus 
Lateral funiculus, spinal cord 
Lateral geniculate nucleus 
Lateral hypothalamic area 
Medial lemniscus 
Lateral reticular nucleus 
Lateral tegmental nucleus 
Mossy fibers, hippocampus 
Motor facial nucleus 
Medial geniculate nucleus 
Lateral mammillary nucleus 
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cleus, scattered perikarya are seen in the parvicellular but 
not magnocellular part of this nucleus (Fig. 2A), as well as 
more laterally surrounding the columns of the fornix (Fig. 
2A). The ventromedial nucleus also contains scattered pos- 
itive perikarya. However, in the supraoptic nucleus, no 
magnocellular perikarya exhibit [Leulenkephalin immuino- 
reactivity, although many positive varicose fibers are seen 
scattered in this nucleus, as well as throughout the hypo- 
thalamus, in dorsomedial and marnmillary nuclei, and in 
lateral and posterior hypothalamic areas. A moderately 
denser accumulation of immunoreactive [Leulenkephalin 
fibers or terminals appears in anterior hypothalamic area, 
as well as parvicellular paraventricular, periventricular, 
ventromedial, and arcuate nuclei. From the mammillary 
Medial mammillary nucleus 
Mesencephalic nucleus, trigeminal 
Mammillothalamic tract 
Nucleus cuneatus 
Nucleus diagonal band (Broca) 
Nucleus gracilis 
Nucleus prepositus hypoglossi 
Nucleus reticularis gigantocellularis 
Nucleus reticularis paragigantocellularis 
Nucleus spinal tract, trigeminal 
Nucleus tractus solitarii 
Lateral vestibular nucleus 
Medial vestibular nucleus 







Lateral parabrachial nucleus 
Medial parabrachial nucleus 
Posterior commissure 




Periventricular nucleus, thalamus 
Paraventricular nucleus 
Nucleus raphe dorsalis 
Nucleus reuniens, thalamus 
Reticular formation 
Nucleus rhomboideus. thalamus 
Nucleus raphe magnus 
Nucleus raphe medianus 
Nucleus raphe pontis 
Superior colliculus 
Stria medullaris thalami 
Substantia nigra, pars compacta 




Spinal tract of trigeminal 
Trigeminal motor nucleus 
Trigeminal sensory nucleus (main) 
Ventricle 
Ventral nucleus of thalamus, anterior 
Ventral nucleus of thalamus, dorsal 
Ventral nucleus of thalamus 
Ventral funiculus, spinal cord 
Ventral horn, spinal cord 
Ventral nucleus, lateral lemniscus 
Ventromedial nucleus. hypothalamus 
Ventral tegmental area 
Zona incerta 
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Fig. 1. These schematic frontal sections show the distribution of m u ] -  
enkephalin perikarya (solid circles) and processes or terminals (dots) in nine 
selected levels through the diencephalon, brainstem, and spinal cord (cervi- 
cal level 1, or Cl). The numbers of perikarya shown in each nucleus or region 
are not meant to be quantitative. The number in the lower center of each 
drawing indicates the distance (mm) of that section from the vertical zero 
plane (modified from Pellegrino et al., 7 9  Paxinos and Watson, '82). See 
text for details. 
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Fig. 2. Hypothalamus. Panel A shows immunoreactive [Leulenkephalin 
perikarya in the parvocellular paraventricular nucleus and to the left of this 
panel many perifornical perikarya also exhibit positive immunoreactivity. 
[Leuknkephalin immunoreactive perikarya can be seen in the medial aspect 
of the medial mammillary nucleus (panel B), as well as  fibers in the memmil- 
lothalamic tract (arrows, panel C). E, Third ventricular ependyma. Bar A = 
100 pm. Bar B,C = 50 p n .  
nuclei, immunoreactive fibers are seen to  enter the mam- 
millothalamic tract, which itself demonstrates positive 
fiber immunoreactivity throughout its entire course (Fig. 
2C) to the anterior nucleus of the thalamus (Fig. 3A). Other 
hypothalamic fiber tracts with immunoreactive [Leulen- 
kephalin fibers include the ventral amygdalofugal tract, 
the medial forebrain bundle, and the external and internal 
(scattered) zones of the median eminence. Many reactive 
terminals end in the vicinity of hypothalamohypophysial 
portal vessels in the external zone of the median eminence. 
In the thalamus, scattered immunoreactive [Leulen- 
kephalin perikarya are localized in the periventricular nu- 
cleus throughout its rostrocaudal extent (Fig. 3B), and in 
the ventral regions of the lateral geniculate nucleus (Fig. 
3C). These areas also contain [Leulenkephalin-positive fi- 
bers, as do anterior thalamic nuclei (see below; Fig. 3A), 
medial geniculate nucleus, nucleus reuniens, nucleus 
rhomboideus, medial nucleus (see below), and lateral and 
medial habenular nuclei. Most of these nuclei contain scat- 
tered reactive fibers and varicosities. However, the peri- 
ventricular and anteroventral thalamic nuclei contain a 
moderately dense distribution of immunoreactive fibers. 
The densest accumulation of [Leulenkephalin-positive ter- 
Fig. 3. Thalamus. Panel A shows adense accumulation of [LeuJenkepha- 
lin immunoreactive terminals in the anterodorsal nucleus. Panel B shows 
immunoreactive perikarya and fibers (arrow) in periventricular nucleus. 
Panel C depicts [Leubnkephalin-positive perikarya in the ventral region of 
the lateral geniculate nucleus. Bar = 50 @I. 
minals in the thalamus appear in the anterodorsal (Fig. 3A) 
and centromedian nuclei. 
In the midbrain region, a dense accumulation of small 
immunoreactive [Leuknkephalin perikarya is seen in the 
central and lateral subdivisions of the interpeduncular rtu- 
cleus (Fig. 4A), and dorsally in the dorsal tegmental nu- 
cleus. Scattered positive perikarya also appear in the ven- 
tral, lateral, and central tegmental nuclei, dorsal and 
ventral nuclei of the lateral lemniscus, substantia nigra 
(only occasional positive perikarya in pars compacta), ven- 
tral tegmental area, both superior and inferior collicluli 
(Fig. 4C), medial nucleus of the optic tract, periaqueduc1,al 
gray (Fig. 4B). oculomotor (occasional), and mesencephalic 
trigeminal nuclei (Fig. 5A). Other scattered [Leulenkepha- 
lin perikarya are seen within the mesencephalic reticular 
formation, forming a band of cells that stretches medially 
and dorsally from a position just dorsal to the lateralmost 
regions of the cerebral peduncles, toward the periaqueduc- 
tal gray. Scattered [Leulenkephalin-positive fibers and ter- 
minals are also noted in aforementioned areas which con- 
tain immunoreactive perikarya, except in the following 
areas which contained a moderate distribution of fibers or 
terminals: all regions of the interpeduncular nucleus, sub- 
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Fig. 4. Mesencephalon. Panel A shows imrnunoreactive Dulenkepha- 
lin perikarya in the central subdivision of the interpeduncular nucleus. 
Scattered [Leu]enkephalin-positive perikarya can be seen in the periaque- 
ductal gray (panel B). Panel C depicts a [Leulenkephalin immunoreactive 
perikaryon within the inferior colliculus. Bar = 50 p m .  
stantia nigra pars cornpacta (and scattered within pars re- 
ticulata), ventral tegmental area, inferior colliculus, and 
periaqueductal gray. 
In the pons, [Leulenkephalin-positive perikarya are seen 
within the periaqueductal gray in the vicinity of the nu- 
cleus raphe dorsalis (but mainly concentrated lateral to 
this serotonergic nucleus), nucleus locus coeruleus (occa- 
sional; Fig. 5A) and subcoeruleus, lateral and medial para- 
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Fig. 5. Pons and cerebellum. Panels A and B are adjacent tissue sections 
through the nucleus locus coeruleus (LC), mesencephalic nucleus of the tri- 
geminal nerve (NMT), and parabrachial nucleus (PBN), showing Feulen- 
kephalin (A) and tyrosine hydroxylase (B) immunureactivity. Note that the 
concentration of [Leubnkephalinpositive perikarya and fibers is relatively 
more dense in the lateral parabrachial nucleus, dorsal to the brachium con- 
junctivum (BC). Panel C shows wuknkephalin-positive perikarya in the 
cerebellar fastigial nucleus. V, fourth ventricle. Bar A.B = 100 pm. Bar C = 
50 p m .  
brachial nuclei (Fig. 5A), motor trigeminal nucleus (occa- 
sional), serotonergic nuclei raphe pontis, raphe magnus 
(Fig. 6A,B), and widely scattered throughout the pontine 
reticular formation. Immunoreactive [Leulenkephalin fi- 
bers are also noted in all of these nuclei and regions, some 
316 H. KHACHATURIAN, M.E. LEWIS, AND S.J. WATSON 
In the medulla, as in the pons, many [Leulenkephalin- 
containing perikarya and fibers are scattered throughout 
the reticular formation. Many reactive perikarya are con- 
centrated in the nucleus raphe magnus (Fig. 6A), nucleus 
reticularis paragigantocellularis (Fig. 6C), lateral reticular 
nucleus, caudal regions of nucleus tractus solitarius (Fig. 
7C), among cells of the A5 noradrenergic cell group (Fig. 
7A,B), and nucleus prepositus hypoglossi. Other scattered 
immunoreactive [Leulenkephalin perikarya are present in 
medial aspects of the nucleus reticularis gigantocellularis, 
substantia gelatinosa of spinal trigeminal nucleus, medial, 
superior, and lateral vestibular nuclei, the cerebellar f as- 
tigial nucleus, and the parvicellular part of the lateral retic- 
ular nucleus. Immunoreactive [Leulenkephalin fibers or 
terminals are present in moderate density in the above- 
mentioned nuclei, with the exception of nucleus reticularis 
gigantocellularis and the vestibular nuclei, which have 
scattered varicosities. Some areas contained moderate-to- 
dense accumulations of keulenkephalin-positive termi- 
nals, including the spinal nucleus of the trigeminal, the 
nucleus tractus solitarii area, and extending ventrally into 
the dorsal motor nucleus of the vagus, hypoglossal nu- 
cleus, and laterally into the reticular formation, forming a 
band continuous with more ventrally located structures, 
including nucleus ambiguus, and lateral reticular nucleus. 
Within the cervical spinal cord, scattered [Leulenkepha- 
lincontaining perikat-ya are concentrated mainly in the 
deeper laminae of the dorsal horn (laminae I11 and V; Fig. 
8B). A dense accumulation of immunoreactive fibers or ter- 
minals is located in the dorsal horn, especially within larni- 
nae I and 11, and to a lesser extent in laminae 111-V (Fig. 
8A). Other scattered positively staining fibers are distr ib- 
uted around the central canal as well as in the ventral gray 
horn in the vicinity of the large spinal motor neurons. 
[Leulenkephalinpositive varicosities are also seen in the 
dorsal aspects of the lateral funiculus near the dorsal gray 
horn (Fig. 8A). 
A schematic summary of the findings of the present 
study and those of a previous study on telencephalic 
enkephalinergic systems (Khachaturian et al., '83) is 
shown in Figure 9. 
Fig. 6. Rostra1 medulla. Panels A and B are adjacent tissue sections 
through the nucleus raphe magnus showing GeuJenkephalin (A) and BAM- 
22P (B) perikaryal immunoreactivities in similar anatomical position (note 
the position of the capillary lumen (star) situated at the midline in both 
panels A and B). Panel C shows immunoreactive [LRuknkephalin perikarya 
within the nucleus reticularis paragigantocellularis. Bar = 100 p m .  
containing relatively greater amounts of positive varicosi- 
ties, including periaqueductal gray, locus coeruleus, lat- 
eral and medial parabrachial nuclei, and nuclei raphe pon- 
tis and raphe magnus. Immunoreactive [Leulenkephalin 
fibers also occur in the main sensory nucleus of the trigem- 
inal, motor facial nucleus, as well as in dorsal and ventral 
cochlear nuclei. 
DISCUSSION 
Rats given relatively high doses of colchicine (300-400 
pghimal)  have been used in this study of the distribution 
of [Leulenkephalin and BAM-22P immunoreactivities in 
diencephalic, brainstem, and spinal cord structures. Clol- 
chicine pretreatment was found to enhance the immuno- 
cytochemical signal obtained using antisera generatled 
against these peptides. In particular, perikarya, especially 
those of parvicellular nuclei, exhibited darker staining 
with the highest doses used (300-400 pg), presumably be- 
cause of the inhibitory action of colchicine upon microtu- 
bule formation (Dahlstrom, '68; Kreutzberg, '69; Norstrom 
et al., '71; Fink et al., '73), which results in a diminution of 
axonal transport and an accumulation of material synthe- 
sized in the perikaryon. Perhaps because of the same ac- 
tion of colchicine, both dendrites and axons also exhibited 
an enhanced visual immunoreactive signal. Despite re- 
ports of neuronal damage following direct intracerebral 
injections of colchicine (Goldschmidt and Steward, '82), we 
did not detect any signs of neuronal damage in Nisal- 
stained sections from rats injected intraventricularly with 
colchicine, although tissue damage did occur in the imme- 
diate vicinity of the cannula injection track. 
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Fig. 7. Caudal medulla. Panels A and B are adjacent tissue sections 
through the A5 noradrenergic cell group showing positive perikarya to 
both keubnkephalin (A) and tyrosine hydroxylase (B). Note the dissimilar 
distribution of bubnkephalin- and tyrosine hydroxylasecontaining p r i -  
karya. Also in A and B, note position of capillary lumen (stars). Panel C 
shows positive (Leu]enkephalincontaining perikarya in the caudal nucleus 
tractus solitarius (C, central canal). Bar = 100 pm. 
Peulenkephalin and BAM-22P immunoreactivities were 
found to be distributed similarly in neuronal perikarya, 
fibers, and terminals in most diencephalic, brainstem and 
spinal cord sites, thus suggesting substantial structural 
similarity between the adrenal proenkephalin precursor 
(Comb et al., '82; Gubler et al., '82; Noda et al., '82) and the 
Fig. 8. Spinal cord. Panel A shows the dorsal horn of the spinal cord 
gray where immunoreactive Leujenkephalin terminals are concentrated 
within laminae I and I1 (arrows). dorsolateral funiculus (lateral to the 
dashed line), and scattered throughout the deeper laminae as well. A lamina 
V ~eujenkephdinantaining perikaryon is shown in panel B. LF, lateral 
funiculus; DF, dorsal funiculus. Bar A = 100 pm. Bar B = 50 pm. 
presently unidentified precursor which occurs in brain 
(Kojima et al., '82). Adj acent-section analysis revealed that 
in the majority of brain sites observed in the present 
study, as well as the preceding study (Khachaturian et al., 
'83). BAM-22P immunoreactivity occurred in areas that 
also contained [Leulenkephdin immunoreactivity, and fur- 
ther, the distributional patterns of these two immuno- 
reactivities within these areas were identical. Since 20-pn 
sections were used in these studies, the question of coloca- 
lization within the same neurons was not approached. 
However, using serial 4 - p n  section analysis, we have 
recently demonstrated the existence of [Leulenkephalin 
and BAM-22P immunoreactivities in the same brain neu- 
rons, reinforcing the hypothesis that the brain and adrenal 
enkephalin precursors are similar (Khachaturian et al., in 
press). Both of these immunoreactivities were shown to be 
specific for their respective peptides, since [Met]- or [Leu]- 
enkephalin, BAM-12P, peptide E, dynorphin A, and 0- 
endorphin did not block the immunoreactive signal ob- 
tained using sera generated against BAM-22P (blocked by 
1 FM BAM-22P), and further, BAM-22P, dynorphin A, and 
0-endorphin did not block the irnmunoreactive signal of 
anti[Leu]enkephalin serum (blocked by 1 pM [Leulen- 
kephalin). 
318 H. KHACHATURTAN, M.E. LEWIS, AND S.J. WATSON 
(LEU)ENKEPHALIN 
PERIKARYA 
- u . .  FIBERS -TERMINALS 
PP PV MF 
Fig. 9. Schematic summary of [Leulenkephalin distribution in the rat central nervous system, 
shown in parasagittal view. Neuronal perikarya are represented by solid triangles, while fibers and 
terminals are shown as dots. See list of abbreviations and text for details. 
[LeuJenkephalin-positive perikarya, fibers, and termi- 
nals are distributed widely throughout the neuraxis. In a 
previous study (Khachaturian et al., '831, we found more 
widespread and extensive enkephalinergic systems in cor- 
tical and limbic structures of the rat brain than had been 
recognized before (Sar et al., '78; Wamsley et al., '80; Finley 
et al., '81). However, the latter investigators, using rela- 
tively high doses of colchicine, were able to visualize en- 
kephalinlike immunoreactivity in many central nervous 
system sites not previously reported. In the preceding re- 
port (Khachaturian et al., '83), we discussed some of the 
similarities and differences between our findings and those 
of others (Finley et al., '81; Gall et al., '81) pertaining to tel- 
encephalic enkephalinergic systems. Below, we discuss 
similarities and differences found with respect to other 
studies of diencephalic, brainstem, and spinal cord enkeph- 
din-containing neurons. Several discrepancies exist be- 
tween the present study and that reported by Finley et d. 
('81): (1) We were unable to demonstrate magnocellular 
hypothalamic perikarya positive for [Leulenkephalin, or a 
dense enkephalinergic pathway through the internal zone 
of the median eminence, as reported; (2) we were also un- 
able to visualize immunoreactive perikarya in the parate- 
nial thalamic nucleus, cochlear nuclei, or granular layer of 
the cerebellar cortex, as reported; (3) in contrast, we have 
noted perikarya in motor trigeminal, mesencephalic ti-i- 
geminal, occulomotor, and prepositus hypoglossi nuclei. 
At least part of the discrepancy between the present study 
and that of Finley et al. ('81 jmay be attributable to differ- 
ences in the antienkephalin sera used in each study. We 
have used an affinity-purified anti[leu]enkephalin seruim 
which has been shown to be highly specific for that mole- 
cule. In contrast, Finley et al. ('81) used antisera that 
detects "not only authentic enkephalin but also other mole- 
cule(s) containing either the enkephalin sequence or unre- 
lated, but cross-reactive, amino acid sequences." Since the 
[Leulenkephalin sequence (Tyr-Gly-Gly-Phe-Leu) is incor- 
porated into the NH2-terminus of dynorphin A, antisera 
generated against either peptide might cross-react with 
both molecules. To address this issue, we have tested anti- 
sera raised against several dynorphin A fragments (1-13, 
1-17,7-17) and [Leulenkephalin, in a serial-section analys~s 
with cross-blocking controls, to demonstrate that dynor- 
phin and enkephalin immunoreactivities are indeed sepa- 
rable in the central nervous system (Watson et al., '82b). 
For example, the hypothalamic magnocellular supraoptic 
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and paraventricular nuclei contain dynorphin-positive 
perikarya but not enkephalin-positive perikarya (Watson 
et al., '81, '82a). This finding may explain the previous ob- 
servations of enkephalinlike immunoreactivity in both the 
cat and rat magnocellular neurons (Micevyeh and Elde, 
'80; Finley et al., '81). Our observation of previously unde- 
tected perikarya in several brainstem nuclei can perhaps 
be attributed to the technical improvement achieved by 
the use of high doses of colchicine. 
The presence of enkephalin-positive perikarya in the 
motor nucleus of the trigeminal indicates a possible role of 
enkephalin in the control of mastication by way of the spe- 
cial visceral efferent component of the trigeminal nerve. 
This possibility is also supported by the finding of immu- 
noreactive perikarya in the mesencephalic nucleus of the 
trigeminal nerve, which receives proprioceptive input re- 
lating to mastication. A role of enkephalin in the regula- 
tion of eye movements is suggested by the finding of 
immunoreactive perikarya in the oculomotor nucleus and 
the prepositus hypoglossal nucleus, an important "preocu- 
lomotor" area as indicated by anatomical (Graybiel and 
Hartwieg, '74) and physiological (Baker et al., '75, '77) 
studies. Our anatomical observations thus indicate possi- 
ble roles of enkephalin which have not previously been 
considered and should be investigated further. Among the 
nuclei mentioned above, dynorphin immunoreactive peri- 
karya have been detected only in the mesencephalic nu- 
cleus of the trigeminal nerve (Khachaturian et al., '82). 
Further differences and parallels have been noted be- 
tween the distribution of [Leulenkephalin and dynorphin 
immunoreactivities. For example, in the substantia nigra, 
[Leulenkephalin-positive varicosities are mainly concen- 
trated in the pars compacta, among dopaminergic neu- 
rons, whereas the major dynorphin component occurs in 
the form of diffuse immunoreactivity in the pars reticulata 
(Khachaturian et al., '82). Other areas where such parallels 
have been found between the distribution of [Leulenkepha- 
lin and dynorphin immunoreactivities include perikarya in 
the periaqueductal gray, parabrachial nuclei, and other 
brainstem nuclei where dynorphin-containing and enkeph- 
alin-containing neurons occur in distinctly separate popu- 
lations. However, in areas such as the nucleus caudate- 
putamen, globus pallidus, nucleus accumbens, as well as in 
the spinal cord, the separation of dynorphin and [Leulen- 
kephalin immunoreactivities has proved to be difficult 
(Khachaturian et al., '82). On the basis of findings showing 
the separate biosynthetic origins of the enkephalins (Comb 
et al., '82; Gubler et  al., '82; Noda et al., '82) and dynorphin 
(Kakidani et al., '82), and our own anatomical observations 
(Watson et al., '82b; Khachaturian et al., in press), it can be 
concluded that dynorphin and the enkephalins form sepa- 
rate opioid systems. Nevertheless, the spatial contiguity 
of these two systems in many areas of the central nervous 
system raises the question of the postsynaptic differentia- 
tion of the "messages" of these peptides. One possibility is 
that enkephalin and dynorphin interact preferentially with 
different opiate receptor subtypes in vivo, as indicated by 
the different affinities of these peptides for S and x recep- 
tors in vitro (Lord et al., "77; Huidobro-Tor0 et al., '81; 
Chavkin et  al., '82). Another possibility, which does not ex- 
clude the first, is that enkephalin and dynorphin interact 
differentially at the same receptor, possibly in different 
conformational states (Bowen et  al., '81; Quirion and Pert, 
'81). A third possibility is the interaction of dynorphin with 
a nonopiate receptor (Walker et al., '82a,b) which may be 
functionally antagonistic to opiate receptors mediating 
morphine analgesia (Tulunay et al., '81), e.g., the pl class of 
sites, which appear to bind opiate alkaloids and enkepha- 
lins equally well with subnanomolar affinities (Wolozin 
and Pasternak, '81). Further analysis of this problem will 
depend upon anatomical studies of opioid peptide-receptor 
relationships (Lewis et al., '82), as well as functional 
studies of enkephalin-dynorphin interactions. 
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